Long Covid Newsletter
Issue #61November 2, 20267 studies

Paxlovid cut long COVID risk by 12% — but only if you were already high-risk

Long COVID research had a busy week, and not everything landed where scientists expected.

From a massive insurance-claims study rewriting the symptom count to a nerve-recording study that couldn't find the autonomic villain everyone assumed was there, the field is getting more honest about what it actually knows.

Paxlovid Helps — But Only for People Who Already Qualified for It

  • Researchers used electronic health records from nearly 500,000 COVID-positive patients to test whether Paxlovid, taken within 5 days of infection, reduced the chance of developing long COVID.
  • Among high-risk patients, it did: treated patients had a 12% lower relative risk and roughly 3 fewer long COVID cases per 100 people compared to untreated high-risk patients.
  • For low-risk patients — no documented risk factors — the association was inconclusive, with the numbers essentially flat.

Why it matters: This is one of the largest real-world estimates yet, and it draws a clean line: Paxlovid's long COVID benefit appears tied to the same population it was already approved for. It doesn't look like a universal preventive.

Top 20% journal 🔗 PLOS global public health Journal Article 🗓️ Oct 28

Key Findings

A Giant Claims Study Just Shrank Long COVID's Symptom List 📉

  • Using 14.4 billion insurance claims from 245 million U.S. patients, researchers found that comparing COVID-positive patients to untested controls inflates the long COVID symptom count dramatically — the unrestricted design attributed 262 symptoms to COVID at 30–119 days post-infection; a test-matched design found 43.
  • Beyond 1 year, the test-based design found zero symptoms attributable to COVID — not because symptoms don't exist, but because their link to COVID specifically becomes statistically indistinguishable from background noise.
💡 Study design alone may have been inflating long COVID's symptom burden for years.
🔗 Proc Natl Acad Sci U S A Journal Article 🗓️ Oct 27

Brain Fog Shows Up on EEG Even When Test Scores Look Fine 🧠

  • Young adults with long COVID, about 6 months after mild infection, showed altered brainwave patterns during an attention-control task and slower background brain oscillations at rest — even though their task performance scores were intact.
  • The EEG signal, not the behavioral score, was where the dysfunction appeared, suggesting standard cognitive tests may be missing something that direct neural recording catches.
💡 Standard cognitive tests may not be sensitive enough to detect long COVID's neural fingerprint.
🔗 NeuroSci Journal Article 🗓️ Oct 26

Exercise Intolerance in Long COVID Isn't Coming From the Heart or Autonomic Nerves

  • In 35 long COVID patients who underwent cardiopulmonary testing, cardiac MRI, and direct nerve-activity recordings during tilt-table testing, heart structure and contractile reserve were normal, and sympathetic nerve output ramped up appropriately with positional stress.
  • Yet 41% still quit the tilt test early due to symptoms, and peak exercise capacity remained lower than in recovered controls — pointing toward afferent signaling problems or impaired brain blood flow rather than an efferent nerve or heart failure.
💡 The autonomic villain long COVID research assumed may not be the right target after all.
🎖️ Top 10% journal 🔗 American journal of physiology. Heart and circulatory physiology Journal Article 🗓️ Oct 26

Long COVID Is Linked to a Higher Chance of Developing Multiple Chronic Conditions

  • In a nationally representative U.S. panel study of 4,356 adults who started without multiple chronic conditions, those with long COVID had more than twice the odds of developing cross-domain multimorbidity compared to people with no COVID history.
  • Cardiometabolic plus respiratory combinations were the most common pattern, appearing in roughly 75% of new multimorbidity cases.
💡 Long COVID may accelerate the path to multiple chronic diseases, not just prolong one.
Top 30% journal 🔗 Healthcare (Basel, Switzerland) Journal Article 🗓️ Oct 27

Exercise Beats Other Non-Drug Approaches for Long COVID Fatigue

  • A meta-analysis of 13 randomized trials covering 1,276 participants found that non-pharmacological interventions as a group significantly reduced fatigue, but exercise training was the only individual category to reach statistical significance on its own.
  • Interventions lasting at least 8 weeks produced larger average improvements than shorter programs — a duration effect that held up in sensitivity analyses.
💡 Eight-plus weeks of exercise currently has the strongest non-drug evidence for long COVID fatigue.
Top 30% journal 🔗 Healthcare (Basel, Switzerland) Review 🗓️ Oct 27

Herpesvirus Reactivation in Saliva Is Associated With Long COVID Severity

  • A case-control study found that salivary HHV-6 DNA levels were associated with long COVID symptom severity, adding to a growing body of evidence linking latent herpesvirus reactivation — not just the original SARS-CoV-2 infection — to persistent post-COVID illness.
  • The study also measured cortisol, testosterone, and estradiol, exploring a potential hormonal connection to viral reactivation in long COVID.
💡 Reactivated dormant herpesviruses, not just SARS-CoV-2 itself, may be driving some long COVID symptoms.
🥈 Top 2% journal 🔗 EBioMedicine Journal Article 🗓️ Oct 27

Implications

The week's clearest throughline: long COVID's mechanisms keep resisting simple explanations. Nerves look normal, hearts look normal, yet patients can't exercise or stand up without symptoms. The biggest open question is whether the problem lives in how the brain receives signals — and whether any current intervention actually targets that.

Studies in this issue

Primary sources used for this newsletter.

  1. Paxlovid's real-world protection against Long COVID in adult outpatients
    main storyPLOS global public health2026-10-28PMID 42949887
  2. Links between saliva levels of HHV-6 virus and long COVID severity
    key findingEBioMedicine2026-10-27PMID 42945894
  3. Standing and exercise problems after COVID-19 occur despite normal nerve signals and heart function
    key findingAmerican journal of physiology. Heart and circulatory physiology2026-10-26PMID 42932937
  4. Updated estimates of the types and length of long COVID symptoms from health records of 245 million US patients
    key findingProceedings of the National Academy of Sciences of the United States of America2026-10-27PMID 42945239
  5. Long COVID linked to new multiple chronic health conditions in the United States over time
    key findingHealthcare (Basel, Switzerland)2026-10-27PMID 42940472

Continue reading

All Long Covid issues